These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24273412)

  • 1. Challenges in measuring and valuing productivity costs, and their relevance in mood disorders.
    Lensberg BR; Drummond MF; Danchenko N; Despiégel N; François C
    Clinicoecon Outcomes Res; 2013; 5():565-73. PubMed ID: 24273412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The iMTA Productivity Cost Questionnaire: A Standardized Instrument for Measuring and Valuing Health-Related Productivity Losses.
    Bouwmans C; Krol M; Severens H; Koopmanschap M; Brouwer W; Hakkaart-van Roijen L
    Value Health; 2015 Sep; 18(6):753-8. PubMed ID: 26409601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production Losses due to Absenteeism and Presenteeism: The Influence of Compensation Mechanisms and Multiplier Effects.
    Brouwer W; Verbooy K; Hoefman R; van Exel J
    Pharmacoeconomics; 2023 Sep; 41(9):1103-1115. PubMed ID: 36856941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Productivity costs in economic evaluations: past, present, future.
    Krol M; Brouwer W; Rutten F
    Pharmacoeconomics; 2013 Jul; 31(7):537-49. PubMed ID: 23620213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do the Washington Panel recommendations hold for Europe: investigating the relation between quality of life versus work-status, absenteeism and presenteeism.
    Knies S; Boonen A; Severens JL
    Cost Eff Resour Alloc; 2014; 12():24. PubMed ID: 25904824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement Instruments of Productivity Loss of Paid and Unpaid Work: A Systematic Review and Assessment of Suitability for Health Economic Evaluations From a Societal Perspective.
    Hubens K; Krol M; Coast J; Drummond MF; Brouwer WBF; Uyl-de Groot CA; Hakkaart-van Roijen L
    Value Health; 2021 Nov; 24(11):1686-1699. PubMed ID: 34711370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Estimation and Inclusion of Presenteeism Costs in Applied Economic Evaluation: A Systematic Review.
    Kigozi J; Jowett S; Lewis M; Barton P; Coast J
    Value Health; 2017 Mar; 20(3):496-506. PubMed ID: 28292496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring and valuing productivity loss due to poor health: A critical review.
    Zhang W; Bansback N; Anis AH
    Soc Sci Med; 2011 Jan; 72(2):185-92. PubMed ID: 21146909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systematic Review of Productivity in Economic Evaluations of Workplace Interventions: A Need for Reporting Criteria?
    Jones C; Verstappen SMM; Payne K
    Appl Health Econ Health Policy; 2019 Oct; 17(5):591-613. PubMed ID: 30937837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to estimate productivity costs in economic evaluations.
    Krol M; Brouwer W
    Pharmacoeconomics; 2014 Apr; 32(4):335-44. PubMed ID: 24504850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of presenteeism for the value of lost production: the case of rheumatoid arthritis.
    Søgaard R; Sørensen J; Linde L; Hetland ML
    Clinicoecon Outcomes Res; 2010; 2():105-12. PubMed ID: 21935319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating productivity costs using the friction cost approach in practice: a systematic review.
    Kigozi J; Jowett S; Lewis M; Barton P; Coast J
    Eur J Health Econ; 2016 Jan; 17(1):31-44. PubMed ID: 25387561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the Effect and Economic Impact of Absenteeism, Presenteeism, and Work Environment-Related Problems on Reductions in Productivity from a Managerial Perspective.
    Strömberg C; Aboagye E; Hagberg J; Bergström G; Lohela-Karlsson M
    Value Health; 2017 Sep; 20(8):1058-1064. PubMed ID: 28964437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating productivity costs in health economic evaluations: a review of instruments and psychometric evidence.
    Tang K
    Pharmacoeconomics; 2015 Jan; 33(1):31-48. PubMed ID: 25169062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in the methodological approach to productivity cost valuation: the case of prostate cancer.
    Hanly P; Maguire R; Drummond F; Sharp L
    Eur J Health Econ; 2019 Dec; 20(9):1399-1408. PubMed ID: 31444674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valuing productivity costs using the friction-cost approach: Estimating friction-period estimates by occupational classifications for the UK.
    Kigozi J; Jowett S; Lewis M; Barton P; Coast J
    Health Econ; 2017 Dec; 26(12):1862-1868. PubMed ID: 28449329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Productivity cost calculations in health economic evaluations: correcting for compensation mechanisms and multiplier effects.
    Krol M; Brouwer WB; Severens JL; Kaper J; Evers SM
    Soc Sci Med; 2012 Dec; 75(11):1981-8. PubMed ID: 22925428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Productivity loss due to absenteeism and presenteeism by different instruments in patients with RA and subjects without RA.
    Braakman-Jansen LM; Taal E; Kuper IH; van de Laar MA
    Rheumatology (Oxford); 2012 Feb; 51(2):354-61. PubMed ID: 22179729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transferability of valuing lost productivity across jurisdictions. differences between national pharmacoeconomic guidelines.
    Knies S; Severens JL; Ament AJ; Evers SM
    Value Health; 2010 Aug; 13(5):519-27. PubMed ID: 20712601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical analysis of economic tools and economic measurement applied to rheumatoid arthritis.
    Her M; Kavanaugh A
    Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S107-11. PubMed ID: 23078839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.